Expanded Access Type: Treatment Investigational New Drug/Protocol
"Expanded access type: treatment investigational new drug (IND)/protocol" allows a large
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
